TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
INDP

Indaptus Therapeutics Inc

Healthcare · Biotechnology

3.30$ -14.5% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Indaptus Therapeutics Inc (INDP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 17.5% of the shares are freely tradable; institutional investors hold 0.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 0.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 97.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 17.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 133Mio.

Largest Shareholders

Institutions

Institutions INDP
Name Stake (%) Shares Change (%) Date
Geode Capital Management, LLC 1.25 27,007 +0.0 03/31/2026
Millennium Management LLC 0.53 11,586 +0.0 06/30/2026
Morgan Stanley - Brokerage Accounts 0.12 2,697 +0.0 03/31/2026
Tower Research Capital LLC 0.09 1,890 -40.0 03/31/2026
SBI Securities Co Ltd 0.00 17 +0.0 03/31/2026
CWM, LLC duplicate 0.00 2 +0.0 03/31/2026

Funds

Funds INDP
Name Stake (%) Shares Change (%) Date
Fidelity Nasdaq Composite Index 0.05 69,403 +0.0 07/31/2026
Fidelity Extended Market Index 0.01 11,474 -5.2 07/31/2026
Morgan Stanley Pathway Sm-Md Cp Eq ETF 0.01 11,002 +0.0 08/31/2026
Fidelity Series Total Market Index 0.00 3,929 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?